(NBIX) Neurocrine Biosciences - Performance -21.7% in 12m
Compare NBIX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
6.43%
#35 in Group
Rel. Strength
25.69%
#5931 in Universe
Total Return 12m
-21.70%
#75 in Group
Total Return 5y
8.36%
#39 in Group
P/E 32.4
77th Percentile in Group
P/E Forward 21.5
69th Percentile in Group
PEG 0.27
67th Percentile in Group
FCF Yield 5.62%
91th Percentile in Group
12m Total Return: NBIX (-21.7%) vs XBI (-1.8%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: NBIX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NBIX
Total Return (including Dividends) | NBIX | XBI | S&P 500 |
---|---|---|---|
1 Month | -2.63% | 2.28% | -0.87% |
3 Months | -29.07% | -10.48% | -7.58% |
12 Months | -21.70% | -1.83% | 11.88% |
5 Years | 8.36% | -12.72% | 110.33% |
Trend Score (consistency of price movement) | NBIX | XBI | S&P 500 |
1 Month | 38.3% | 56.6% | 23% |
3 Months | -87.6% | -89.3% | -88.5% |
12 Months | -57.6% | -42.4% | 55.1% |
5 Years | 50.6% | -53.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #132 | -4.80% | -1.78% |
3 Month | #136 | -20.8% | -23.3% |
12 Month | #75 | -20.2% | -30.0% |
5 Years | #41 | 24.2% | -48.5% |
FAQs
Does NBIX Neurocrine Biosciences outperforms the market?
No,
over the last 12 months NBIX made -21.70%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months NBIX made -29.07%, while XBI made -10.48%.
Over the last 3 months NBIX made -29.07%, while XBI made -10.48%.
Performance Comparison NBIX vs Indeces and Sectors
NBIX vs. Indices NBIX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.76% | -1.76% | -8.60% | -33.6% |
US NASDAQ 100 | QQQ | -0.27% | -4.03% | -9.03% | -34.4% |
US Dow Jones Industrial 30 | DIA | 1.70% | 0.55% | -8.51% | -30.9% |
German DAX 40 | DAX | 1.99% | -3.95% | -28.1% | -46.4% |
Shanghai Shenzhen CSI 300 | CSI 300 | 4.72% | 0.19% | -5.61% | -27.7% |
Hongkong Hang Seng | HSI | 1.75% | -2.69% | -10.5% | -35.6% |
India NIFTY 50 | INDA | 3.60% | -6.69% | -8.89% | -24.8% |
Brasil Bovespa | EWZ | 1.56% | -7.23% | -12.3% | -15.9% |
NBIX vs. Sectors NBIX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 0.51% | -1.58% | -14.7% | -45.7% |
Consumer Discretionary | XLY | 0.68% | -2.53% | -11.1% | -35.0% |
Consumer Staples | XLP | 4.26% | -2.83% | -13.9% | -32.9% |
Energy | XLE | 5.24% | 11.2% | -2.81% | -10.6% |
Financial | XLF | 2.15% | -0.52% | -16.2% | -44.4% |
Health Care | XLV | 0.84% | 1.16% | -6.91% | -23.4% |
Industrial | XLI | 0.34% | -2.74% | -9.31% | -31.3% |
Materials | XLB | 1.37% | -0.20% | -1.19% | -18.2% |
Real Estate | XLRE | 2.28% | -1.32% | -7.71% | -39.8% |
Technology | XLK | -1.69% | -4.32% | -5.26% | -29.4% |
Utilities | XLU | 3.60% | -2.69% | -10.7% | -43.5% |
Aerospace & Defense | XAR | -0.19% | -9.02% | -22.1% | -48.3% |
Biotech | XBI | -0.54% | -4.91% | 4.04% | -19.9% |
Homebuilder | XHB | 1.45% | -0.36% | 6.21% | -14.7% |
Retail | XRT | 2.33% | -2.07% | -3.03% | -19.0% |